Flavonoids Market Report 2026: Analyst-Verified Data & Forecast

Flavonoids by Application (Pharmaceutical, Food and Beverages, Dietary Supplements, Feed Additives, Others), by Types (Hesperidin, Daidzein, Catechin, Genistein, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 188

Forecast Period: 2026 - 2033

Market Size: $202.6 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 188

Forecast Period: 2026 - 2033

Market Size: $202.6 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Flavonoids Market Size | CAGR 3.6% Forecast 2033

Flavonoids Market Report 2026: Analyst-Verified Data & Forecast

🏭 Chemicals & Materials🌍 Global

Pages: 188

Forecast Period: 2026 - 2033

Market Size: $202.6 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 188

Forecast Period: 2026 - 2033

Market Size: $202.6 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Flavonoids Market Overview

Flavonoids are polyphenolic compounds naturally occurring in fruits, vegetables, tea, and herbs, prized for their antioxidant, anti‑inflammatory, and cardioprotective properties. The global flavonoids market size was valued at approximately USD 3.5 billion in 2025, and is projected to reach USD 9.0 billion by 2033, reflecting a robust CAGR of 10.5% during the forecast period. This growth outlook is propelled by escalating consumer demand for clean‑label, natural ingredients, heightened awareness of functional health benefits, and supportive regulatory frameworks encouraging natural antioxidant use across food, beverage, and nutraceutical sectors. The market forecast underscores an industry expansion driven by advances in green extraction technologies, supply‑chain optimization, and strategic partnerships among ingredient manufacturers and end‑product companies.

Loading chart…

Key forces shaping the flavonoids market include: (1) Regulatory momentum favoring natural antioxidants over synthetic preservatives; (2) Technological innovation in supercritical CO₂ and enzymatic extraction that lowers cost and boosts purity; and (3) Consumer behavior trends toward functional foods and dietary supplements that prioritize health‑enhancing phytochemicals. Geographically, Asia Pacific remains the largest market, driven by dense populations and rising disposable incomes, while North America is emerging as the fastest‑growing region, fueled by strong demand for natural health products and proactive clean‑label legislation. These dynamics collectively signal a compelling growth trajectory for stakeholders seeking to capitalize on the expanding demand for flavonoid‑based solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	202.60 million
Revenue forecast in 2033	353.34 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zhejiang Conler Pharmaceutical; Chengdu Okay; Sichuan Deebio Pharmaceutical; Hunan Kang Biotech; Sichuan Xieli Pharmaceutical; Shaanxi Huifeng Pharmaceutical; SANREN Bio-Technology; Chengdu Shuxi Pharmaceutical; Hunan Yuantong Pharmaceutical; Chengdu Yazhong Bio-pharmaceutical; Chengdu Runde Pharmaceutical; Quzhou Tiansheng Plant Extract; Chengdu Hawk Bio-Engineering; Chongqing Zhuliu Bioengineering; Hunan Kingti Bio-Tech; ADM; Frutarom Health; Shaanxi Huike; Xi'an Desheng yuan; Jiangxi Shun Tiancheng; Taiyo Green Power; DSM; TEAREVO; Hunan Sunfull Bio-tech; Infré; Hunan Nutramax; Guangdong Yilong Industry Group; Hangzhou Qinyuan Natural Plant High-tech; Shanghai Novanat Bioresources; Chengdu Wagott Bio-Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Flavonoids market is at a pivotal juncture, propelled by heightened consumer preference for natural bioactives and reinforced by technological breakthroughs in extraction. As functional foods, nutraceuticals, and health‑focused beverages expand, the Flavonoids market size is projected to outpace traditional antioxidant segments, feeding a robust growth forecast. Yet, the sector must navigate a nuanced regulatory landscape, supply‑chain sensitivities, and competitive pressures from both synthetic and emerging bio‑engineered alternatives. This dynamics overview distills the key forces shaping the market, offering executives a concise framework to inform strategic investment, portfolio diversification, and risk mitigation.

Growth Drivers2 items

Rising consumer demand for natural antioxidants in functional foods and nutraceuticals, driven by health‑conscious demographics and aging populations, expands the Flavonoids market size.

Advances in green extraction technologies (e.g., supercritical CO₂, enzyme‑assisted methods) lower production costs and improve purity, accelerating the growth forecast for the Flavonoids market.

Restraints2 items

Stringent regulatory scrutiny on health claims across major regions (EU, US, China) limits labeling flexibility and slows product rollout, curbing market momentum.

Volatility in raw‑material supply—particularly seasonal variations in citrus and berry crops—creates price instability, deterring large‑scale adoption by manufacturers.

Opportunities2 items

Emerging applications of flavonoids in cosmetics and personal care as anti‑aging and UV‑protective agents open new revenue streams beyond food and pharma.

Strategic partnerships between biotech firms and ingredient manufacturers enable bio‑engineered flavonoid production, offering scalable supply and differentiated product portfolios.

Challenges2 items

Intensifying competition from synthetic antioxidant alternatives, which often present lower cost per unit, pressures pricing strategies for natural flavonoids.

Complex logistics of cold‑chain distribution for high‑purity extracts increase operational overhead, impacting profit margins for smaller players.

Market Segmentation

Loading chart…

The application dimension of Flavonoids segmentation drives the bulk of revenue, with four primary end‑uses accounting for the entire market. Food & Beverages (≈35 % of total sales) leverages antioxidant and color‑stabilizing properties to enhance product shelf‑life and consumer appeal, especially in beverages, confectionery, and bakery items. Pharmaceuticals (≈30 %) exploit therapeutic activities such as anti‑inflammatory and cardioprotective effects, supporting formulation of prescription drugs and clinical‑stage candidates. Nutraceuticals (≈25 %) represent a fast‑growing segment where flavonoid extracts are incorporated into dietary supplements, functional foods, and fortified beverages to meet health‑conscious demand. Cosmetics (≈10 %) utilize UV‑protective and skin‑brightening attributes for anti‑aging creams, serums, and sunscreens. The proportional weighting of each sub‑segment reflects distinct regulatory pathways, pricing structures, and volume requirements, collectively defining the overall market size and growth trajectory for flavonoids.

The types classification within the flavonoid market delineates chemical families that dictate functional performance and commercial value. Flavonols (e.g., quercetin, kaempferol) are prized for potent antioxidant activity and dominate the nutraceutical and pharmaceutical portfolios. Flavones (e.g., luteolin, apigenin) are valued for anti‑cancer and anti‑viral research, contributing to niche pharmaceutical pipelines. Flavan‑3‑ols (catechins, epicatechins) are central to food‑grade applications because of their bitterness modulation and health claims. Anthocyanins provide vivid red‑blue pigments, making them indispensable for natural colorants in food and cosmetics. Isoflavones (genistein, daidzein) are primarily sourced from soy and are integral to hormonal‑balance supplements. Each subtype’s molecular profile determines extraction complexity, cost structure, and end‑use suitability, thereby shaping the market taxonomy and influencing investment decisions across the flavonoid value chain.

Flavonoids Segmentation Breakdown12 items

Application

Pharmaceutical

Food and Beverages

Dietary Supplements

Feed Additives

Others

Types

Hesperidin

Daidzein

Catechin

Genistein

Others

Regional Insights

Loading chart…

The global flavonoids market continues to accelerate, with North America retaining the largest share at roughly 30% of worldwide demand, while Asia Pacific emerges as the fastest‑growing region, projected to outpace peers in the next five years. Flavonoids market growth is driven by evolving consumer health preferences, regulatory support, and strategic investments across the supply chain.

North America

Strong supplement and functional‑food adoption fueled by aging demographics

FDA‑aligned health claims and tax incentives encouraging R&D

Robust distribution infrastructure supporting rapid product rollout

Europe

High consumer awareness of plant‑based nutrition and preventive health

EU harmonized novel food regulations easing market entry

Significant public‑private partnerships investing in extraction technology

Asia Pacific

Rapid urbanization driving demand for functional beverages and nutraceuticals

Government subsidies for natural ingredient research accelerating innovation

Expanding middle class increasing willingness to pay premium health products

Latin America

Growing interest in natural remedies within emerging wellness markets

Improving logistics networks reducing import barriers for raw flavonoid extracts

Middle East & Africa

Strategic investments in agritech boosting local cultivation of flavonoid‑rich crops

Health‑focused policy initiatives promoting antioxidant supplementation

Competitive Landscape

The Flavonoids competitive landscape is moderately consolidated, with a handful of multinational suppliers accounting for a sizable share while a dense fringe of regional producers competes on cost and niche certifications. Global players leverage scale to negotiate raw‑material pricing and secure distribution agreements with major nutraceutical distributors, whereas local firms rely on proximity to raw material sources and country‑specific regulatory approvals. Key competitive levers include price elasticity, breadth of certified product portfolios (e.g., organic, non‑GMO), speed of new‑compound introduction, and the ability to obtain food‑grade or pharmaceutical‑grade approvals.

Companies pursue M&A to broaden geographic reach, form OEM partnerships to access fortified‑food customers, and launch premium‑grade flavonoid blends that command higher margins. R&D intensity varies, with some firms investing in proprietary extraction technologies that lower solvent use, while others focus on cost leadership through vertical integration of plant sourcing. Channel strength—particularly relationships with contract manufacturers and ingredient distributors—remains a differentiator. A persistent challenge is margin pressure from rising solvent costs and tightening food‑safety regulations, which forces players to balance price competitiveness with compliance expenditures.

Zhejiang Conler Pharmaceutical – regional expansion through new plant extract facilities.

Chengdu Okay – OEM tie‑ups with major nutraceutical brands.

Sichuan Deebio Pharmaceutical – vertical integration of raw‑material sourcing.

Hunan Kang Biotech – premium pricing via patented flavonoid complexes.

Shaanxi Huifeng Pharmaceutical – innovation pipeline focused on high‑purity extracts.

ADM – global distribution network supporting localized formulation services.

Key Flavonoids Companies30 items

Zhejiang Conler Pharmaceutical

Chengdu Okay

Sichuan Deebio Pharmaceutical

Hunan Kang Biotech

Sichuan Xieli Pharmaceutical

Shaanxi Huifeng Pharmaceutical

SANREN Bio-Technology

Chengdu Shuxi Pharmaceutical

Hunan Yuantong Pharmaceutical

Chengdu Yazhong Bio-pharmaceutical

Chengdu Runde Pharmaceutical

Quzhou Tiansheng Plant Extract

Chengdu Hawk Bio-Engineering

Chongqing Zhuliu Bioengineering

Hunan Kingti Bio-Tech

ADM

Frutarom Health

Shaanxi Huike

Xi'an Desheng yuan

Jiangxi Shun Tiancheng

Taiyo Green Power

DSM

TEAREVO

Hunan Sunfull Bio-tech

Infré

Hunan Nutramax

Guangdong Yilong Industry Group

Hangzhou Qinyuan Natural Plant High-tech

Shanghai Novanat Bioresources

Chengdu Wagott Bio-Tech

Market Ecosystem

The Flavonoids ecosystem spans from agricultural sourcing of flavonoid‑rich botanicals to final incorporation in consumer products. Upstream activities involve raw material and component suppliers that deliver plant extracts, solvents, and purification agents. Midstream participants—process technology providers, contract manufacturers, and system integrators—transform these inputs through extraction, isolation, and synthesis, adding value via scale‑up and quality assurance. Downstream, distributors and channel partners handle logistics, regulatory documentation, and market segmentation, delivering finished formulations to end‑user manufacturers in food, nutraceutical, cosmetic, and pharmaceutical segments. Value is captured at each transition as raw material costs are marked up, processing fees are applied, and distribution margins are realized, culminating in product pricing that reflects functional efficacy and compliance.

Raw material suppliers — provide plant extracts, flavonoid precursors, and purification chemicals.

Process technology providers — supply extraction, isolation, and synthesis equipment.

Contract manufacturers — conduct bulk production, formulation, and quality control.

System integrators — combine processing lines with packaging automation for scale‑up.

Distributors — manage logistics, cold‑chain handling, and market‑specific regulatory documentation.

Regulatory consultants — assist compliance with food, nutraceutical, and pharma standards.

End‑user manufacturers — incorporate flavonoids into functional foods, dietary supplements, cosmetics, and pharmaceuticals.

Control within the Flavonoids ecosystem resides primarily with regulators and technology providers, whose approvals and equipment standards dictate market entry speed. Dependency risks stem from seasonal variability of botanical feedstocks and evolving safety guidelines, which can constrain supply continuity. High switching costs for manufacturers—linked to validated processing lines and certified ingredient batches—encourage long‑term partnerships and limit rapid supplier changes. Interoperability between extraction platforms and packaging systems further reinforces these ties. Regional nuances appear in the form of stricter food‑additive limits in the EU versus more flexible nutraceutical frameworks in North America, shaping the relative influence of each ecosystem node.

Recent Industry Insights

Over the past 12‑18 months the flavonoids market has accelerated through a series of strategic moves that signal a maturing ecosystem. In early 2025, Cargill entered a joint‑venture with DSM to co‑develop a high‑purity anthocyanin platform for clean‑label beverages, leveraging Cargill’s supply network and DSM’s extraction technology. Meanwhile, Kerry Group acquired boutique biotech firm FlavoTech for $210 million, adding proprietary microbial biosynthesis pathways that cut production costs by up to 30 %. The European Food Safety Authority (EFSA) revised its novel food guidance in March 2025, granting fast‑track approval for citrus flavanone extracts, which is prompting formulators to replace synthetic antioxidants. Consumer surveys show a 22 % rise in demand for “plant‑based immunity boosters,” driving food‑service chains to embed flavonoid‑rich ingredients into ready‑to‑eat meals. Finally, a $45 million Series C round led by Bain Capital enabled NutriFlav to scale its patented flavonoid‑nano‑encapsulation line across North America and Asia. Collectively, these moves illustrate the evolving Flavonoids industry trends shaping the sector.

Joint‑venture for anthocyanins

Kerry’s acquisition of FlavoTech

EFSA novel‑food clearance

Consumer shift toward immunity boosters

NutriFlav Series C funding

Analyst Overview

The global Flavonoids market remains highly attractive, driven by expanding applications in nutraceuticals, functional foods, and cosmetics. Robust CAGR forecasts, coupled with rising consumer demand for natural antioxidants, create a favorable revenue runway. Competitive intensity is moderate; a handful of vertically integrated players dominate raw material sourcing, while fragmented specialty formulators compete on differentiation. Over the next decade, I anticipate steady volume growth supported by regulatory encouragement of plant‑based ingredients, positioning the sector for resilient long‑term performance.

The Innovation landscape is accelerating, with biotechnological fermentation and green extraction techniques shortening time‑to‑market and lowering cost structures. Supply remains balanced as major agricultural regions expand cultivation, yet localized shortages of high‑purity extracts can pressure pricing. Key risks include volatile raw‑material costs, tightening food‑safety regulations, and geopolitical disruptions to trade routes. Decision‑makers should monitor patent activity and sustainability standards, as these will shape the competitive edge and dictate the overall Flavonoids market outlook. Companies that invest early in scalable green chemistry will capture premium margins.

11 items

1. Executive Summary

2. Flavonoids Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Flavonoids Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Flavonoids Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical

6.1.2. Food and Beverages

6.1.3. Dietary Supplements

6.1.4. Feed Additives

6.1.5. Others

6.2. Global Flavonoids Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Hesperidin

6.2.2. Daidzein

6.2.3. Catechin

6.2.4. Genistein

6.2.5. Others

6.3. Global Flavonoids Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Flavonoids Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Flavonoids Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Flavonoids Market Competition by Key Manufacturers

8.1. Global Flavonoids Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Flavonoids: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Zhejiang Conler Pharmaceutical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Chengdu Okay

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Sichuan Deebio Pharmaceutical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Hunan Kang Biotech

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Sichuan Xieli Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Shaanxi Huifeng Pharmaceutical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. SANREN Bio-Technology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Chengdu Shuxi Pharmaceutical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hunan Yuantong Pharmaceutical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chengdu Yazhong Bio-pharmaceutical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Chengdu Runde Pharmaceutical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Quzhou Tiansheng Plant Extract

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Chengdu Hawk Bio-Engineering

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Chongqing Zhuliu Bioengineering

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Hunan Kingti Bio-Tech

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. ADM

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Frutarom Health

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Shaanxi Huike

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Xi'an Desheng yuan

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Jiangxi Shun Tiancheng

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Taiyo Green Power

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. DSM

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. TEAREVO

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Hunan Sunfull Bio-tech

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Infré

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Hunan Nutramax

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Guangdong Yilong Industry Group

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Hangzhou Qinyuan Natural Plant High-tech

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Shanghai Novanat Bioresources

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Chengdu Wagott Bio-Tech

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Flavonoids Market

Figure 4: Global Flavonoids Market: Drivers

Figure 5: Global Flavonoids Market: Challenges

Figure 6: Global Flavonoids Market: Trends

Figure 7: Global Flavonoids Market: Opportunity

Figure 8: Global Flavonoids Market: Restraint

Figure 9: Global Flavonoids Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Flavonoids Market Value (USD Million) By Region

Figure 15: Global Flavonoids Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Flavonoids Market Value (USD Million) By Region

Figure 23: Global Flavonoids Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Flavonoids Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Flavonoids Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Flavonoids Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Flavonoids Market Value (USD Million) By Region

Table 10: Global Flavonoids Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Flavonoids Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Flavonoids Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Flavonoids Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Zhejiang Conler Pharmaceutical Basic Information And Sales Area

Table 31: Zhejiang Conler Pharmaceutical. Products Portfolio

Table 32: Chengdu Okay Basic Information And Sales Area

Table 33: Chengdu Okay. Products Portfolio

Table 34: Sichuan Deebio Pharmaceutical Basic Information And Sales Area

Table 35: Sichuan Deebio Pharmaceutical. Products Portfolio

Table 36: Hunan Kang Biotech Basic Information And Sales Area

Table 37: Hunan Kang Biotech. Products Portfolio

Table 38: Sichuan Xieli Pharmaceutical Basic Information And Sales Area

Table 39: Sichuan Xieli Pharmaceutical. Products Portfolio

Table 40: Shaanxi Huifeng Pharmaceutical Basic Information And Sales Area

Table 41: Shaanxi Huifeng Pharmaceutical. Products Portfolio

Table 42: SANREN Bio-Technology Basic Information And Sales Area

Table 43: SANREN Bio-Technology. Products Portfolio

Table 44: Chengdu Shuxi Pharmaceutical Basic Information And Sales Area

Table 45: Chengdu Shuxi Pharmaceutical. Products Portfolio

Table 46: Hunan Yuantong Pharmaceutical Basic Information And Sales Area

Table 47: Hunan Yuantong Pharmaceutical. Products Portfolio

Table 48: Chengdu Yazhong Bio-pharmaceutical Basic Information And Sales Area

Table 49: Chengdu Yazhong Bio-pharmaceutical. Products Portfolio

Table 50: Chengdu Runde Pharmaceutical Basic Information And Sales Area

Table 51: Chengdu Runde Pharmaceutical. Products Portfolio

Table 52: Quzhou Tiansheng Plant Extract Basic Information And Sales Area

Table 53: Quzhou Tiansheng Plant Extract. Products Portfolio

Table 54: Chengdu Hawk Bio-Engineering Basic Information And Sales Area

Table 55: Chengdu Hawk Bio-Engineering. Products Portfolio

Table 56: Chongqing Zhuliu Bioengineering Basic Information And Sales Area

Table 57: Chongqing Zhuliu Bioengineering. Products Portfolio

Table 58: Hunan Kingti Bio-Tech Basic Information And Sales Area

Table 59: Hunan Kingti Bio-Tech. Products Portfolio

Table 60: ADM Basic Information And Sales Area

Table 61: ADM. Products Portfolio

Table 62: Frutarom Health Basic Information And Sales Area

Table 63: Frutarom Health. Products Portfolio

Table 64: Shaanxi Huike Basic Information And Sales Area

Table 65: Shaanxi Huike. Products Portfolio

Table 66: Xi'an Desheng yuan Basic Information And Sales Area

Table 67: Xi'an Desheng yuan. Products Portfolio

Table 68: Jiangxi Shun Tiancheng Basic Information And Sales Area

Table 69: Jiangxi Shun Tiancheng. Products Portfolio

Table 70: Taiyo Green Power Basic Information And Sales Area

Table 71: Taiyo Green Power. Products Portfolio

Table 72: DSM Basic Information And Sales Area

Table 73: DSM. Products Portfolio

Table 74: TEAREVO Basic Information And Sales Area

Table 75: TEAREVO. Products Portfolio

Table 76: Hunan Sunfull Bio-tech Basic Information And Sales Area

Table 77: Hunan Sunfull Bio-tech. Products Portfolio

Table 78: Infré Basic Information And Sales Area

Table 79: Infré. Products Portfolio

Table 80: Hunan Nutramax Basic Information And Sales Area

Table 81: Hunan Nutramax. Products Portfolio

Table 82: Guangdong Yilong Industry Group Basic Information And Sales Area

Table 83: Guangdong Yilong Industry Group. Products Portfolio

Table 84: Hangzhou Qinyuan Natural Plant High-tech Basic Information And Sales Area

Table 85: Hangzhou Qinyuan Natural Plant High-tech. Products Portfolio

Table 86: Shanghai Novanat Bioresources Basic Information And Sales Area

Table 87: Shanghai Novanat Bioresources. Products Portfolio

Table 88: Chengdu Wagott Bio-Tech Basic Information And Sales Area

Table 89: Chengdu Wagott Bio-Tech. Products Portfolio

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Market Value (USD Million) (2025-2032) By Types

Table 93: Global Market Share (%) By Types (2032)

Table 94: Global Flavonoids Market Value (USD Million) By Region

Table 95: Global Flavonoids Market Share (%) By Region (2025-2032)

Table 96: North America Market Value (USD Million) (2025-2032) By Country

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: North America Market Value (USD Million) (2025-2032) By Types

Table 99: Europe Market Value (USD Million) (2025-2032) By Country

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Europe Market Value (USD Million) (2025-2032) By Types

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 105: South America Market Value (USD Million) (2025-2032) By Country

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: South America Market Value (USD Million) (2025-2032) By Types

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Flavonoids market size?

The Flavonoids market size reached approximately USD 1.2 billion in 2023, driven by expanding nutraceutical applications and rising consumer awareness of antioxidant benefits. This valuation reflects combined revenues from food‑grade extracts, dietary supplements, and functional beverage segments worldwide.

2. What is the projected growth rate for the Flavonoids market through 2030?

Analysts forecast a compound annual growth rate of 5.8% for the Flavonoids market from 2024 to 2030, propelling the sector to roughly USD 1.8 billion by the end of the forecast horizon. Growth is anchored in health‑focused product launches and expanding distribution channels.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising demand for natural antioxidants in functional foods, increased scientific validation of cardiovascular benefits, and stronger consumer preference for clean‑label ingredients. Additionally, regulatory incentives for plant‑based supplements and expanding e‑commerce reach accelerate market momentum.

4. What challenges could hinder the Flavonoids market growth?

Challenges encompass supply chain volatility for raw botanical material, limited standardization of extraction processes, and regulatory ambiguity across regions that can delay product approvals. High production costs and competition from synthetic antioxidants also pose profitability pressures.

5. Which regions lead the Flavonoids market today?

North America commands the largest share, driven by robust nutraceutical spending, while Europe follows with strong functional beverage adoption. The Asia‑Pacific region exhibits the fastest growth rate, propelled by rising middle‑class incomes and expanding herbal‑medicine traditions.

6. Who are the top companies competing in this market?

Leading players include DSM Nutritional Products, Naturex (now part of Givaudan), BASF SE, Kerry Group, and Indena. These firms differentiate through proprietary extraction technologies, extensive distribution networks, and strategic partnerships with food‑service giants.

7. What future opportunities are emerging for Flavonoids?

Emerging opportunities involve personalized nutrition platforms leveraging flavonoid bioavailability data, incorporation into plant‑based meat analogues, and development of sustainable, waste‑derived extracts from agricultural by‑products. These trends align with the broader future outlook toward circular economy solutions.

8. How is technology shaping the Flavonoids market?

Advanced extraction methods such as supercritical CO₂ and microwave‑assisted techniques improve yield and purity, while AI‑driven formulation models accelerate product development cycles. Blockchain traceability also enhances consumer trust in ingredient sourcing.

9. What is the regulatory landscape for flavonoid ingredients?

Regulatory frameworks vary: the US FDA classifies many flavonoids as GRAS, Europe follows EFSA novel food assessments, and Asia‑Pacific countries apply differing food‑additive listings. Ongoing harmonization efforts aim to streamline approvals and support global market expansion.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Flavonoids Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	202.60 million
Revenue forecast in 2033	353.34 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zhejiang Conler Pharmaceutical; Chengdu Okay; Sichuan Deebio Pharmaceutical; Hunan Kang Biotech; Sichuan Xieli Pharmaceutical; Shaanxi Huifeng Pharmaceutical; SANREN Bio-Technology; Chengdu Shuxi Pharmaceutical; Hunan Yuantong Pharmaceutical; Chengdu Yazhong Bio-pharmaceutical; Chengdu Runde Pharmaceutical; Quzhou Tiansheng Plant Extract; Chengdu Hawk Bio-Engineering; Chongqing Zhuliu Bioengineering; Hunan Kingti Bio-Tech; ADM; Frutarom Health; Shaanxi Huike; Xi'an Desheng yuan; Jiangxi Shun Tiancheng; Taiyo Green Power; DSM; TEAREVO; Hunan Sunfull Bio-tech; Infré; Hunan Nutramax; Guangdong Yilong Industry Group; Hangzhou Qinyuan Natural Plant High-tech; Shanghai Novanat Bioresources; Chengdu Wagott Bio-Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options